Unresolved disorder model. using A ATOM 179 CB AASP 22 9.372 9.609 40.137 0.60 11.30 C Unresolved disorder model. using A ATOM 180 CB BASP 22 9.341 9.646 40.108 0.40 11.17 C Unresolved disorder model. using A ATOM 181 CG AASP 22 9.271 10.915 39.352 0.60 12.03 C Unresolved disorder model. using A ATOM 182 CG BASP 22 10.747 9.276 39.648 0.40 11.56 C Unresolved disorder model. using A ATOM 183 OD1AASP 22 8.269 11.140 38.646 0.60 12.16 O Unresolved disorder model. using A ATOM 184 OD1BASP 22 11.016 8.079 39.397 0.40 12.39 O Unresolved disorder model. using A ATOM 185 OD2AASP 22 10.208 11.736 39.459 0.60 15.29 O Unresolved disorder model. using A ATOM 186 OD2BASP 22 11.593 10.190 39.540 0.40 12.23 O Unresolved disorder model. using A ATOM 188 CA ALYS 23 4.589 9.507 39.566 0.50 8.91 C Unresolved disorder model. using A ATOM 189 CA BLYS 23 4.587 9.517 39.551 0.50 9.10 C Unresolved disorder model. using A ATOM 192 CB ALYS 23 4.297 10.891 38.969 0.50 9.24 C Unresolved disorder model. using A ATOM 193 CB BLYS 23 4.297 10.877 38.902 0.50 9.50 C Unresolved disorder model. using A ATOM 194 CG ALYS 23 5.069 12.041 39.622 0.50 10.71 C Unresolved disorder model. using A ATOM 195 CG BLYS 23 5.155 12.027 39.423 0.50 11.77 C Unresolved disorder model. using A ATOM 196 CD ALYS 23 4.521 12.391 40.993 0.50 11.51 C Unresolved disorder model. using A ATOM 197 CD BLYS 23 4.731 12.467 40.816 0.50 13.92 C Unresolved disorder model. using A ATOM 198 CE ALYS 23 5.295 13.542 41.629 0.50 12.30 C Unresolved disorder model. using A ATOM 199 CE BLYS 23 5.730 13.446 41.434 0.50 16.29 C Unresolved disorder model. using A ATOM 200 NZ ALYS 23 4.629 14.017 42.863 0.50 11.99 N Unresolved disorder model. using A ATOM 201 NZ BLYS 23 5.980 14.640 40.579 0.50 17.22 N Unresolved disorder model. using A ATOM 427 C AASP 51 -6.895 -0.667 25.636 0.70 3.72 C Unresolved disorder model. using A ATOM 428 C BASP 51 -6.858 -0.640 25.549 0.30 3.55 C Unresolved disorder model. using A ATOM 429 O AASP 51 -7.326 -1.742 25.220 0.70 3.89 O Unresolved disorder model. using A ATOM 430 O BASP 51 -7.209 -1.659 24.957 0.30 3.47 O Unresolved disorder model. using A ATOM 431 CB AASP 51 -9.154 0.242 26.302 0.70 5.32 C Unresolved disorder model. using A ATOM 432 CB BASP 51 -9.078 0.175 26.401 0.30 4.64 C Unresolved disorder model. using A ATOM 433 CG AASP 51 -9.064 -0.142 27.764 0.70 8.35 C Unresolved disorder model. using A ATOM 434 CG BASP 51 -9.893 1.382 26.834 0.30 6.01 C Unresolved disorder model. using A ATOM 435 OD1AASP 51 -7.961 -0.180 28.349 0.70 11.53 O Unresolved disorder model. using A ATOM 436 OD1BASP 51 -9.305 2.455 27.085 0.30 6.89 O Unresolved disorder model. using A ATOM 437 OD2AASP 51 -10.150 -0.412 28.336 0.70 11.86 O Unresolved disorder model. using A ATOM 438 OD2BASP 51 -11.131 1.253 26.929 0.30 7.65 O Unresolved disorder model. using A ATOM 447 CA ALYS 53 -5.303 -4.780 28.005 0.50 3.73 C Unresolved disorder model. using A ATOM 448 CA BLYS 53 -5.305 -4.780 28.003 0.50 3.73 C Unresolved disorder model. using A ATOM 451 CB ALYS 53 -6.731 -5.323 27.962 0.50 4.43 C Unresolved disorder model. using A ATOM 452 CB BLYS 53 -6.742 -5.313 27.959 0.50 4.43 C Unresolved disorder model. using A ATOM 453 CG ALYS 53 -7.826 -4.330 28.325 0.50 6.61 C Unresolved disorder model. using A ATOM 454 CG BLYS 53 -7.852 -4.256 28.019 0.50 6.47 C Unresolved disorder model. using A ATOM 455 CD ALYS 53 -9.176 -5.030 28.316 0.50 9.72 C Unresolved disorder model. using A ATOM 456 CD BLYS 53 -7.825 -3.478 29.327 0.50 9.94 C Unresolved disorder model. using A ATOM 457 CE ALYS 53 -10.328 -4.084 28.588 0.50 11.72 C Unresolved disorder model. using A ATOM 458 CE BLYS 53 -9.208 -3.021 29.748 0.50 12.43 C Unresolved disorder model. using A ATOM 459 NZ ALYS 53 -11.621 -4.831 28.532 0.50 13.20 N Unresolved disorder model. using A ATOM 460 NZ BLYS 53 -9.133 -1.946 30.776 0.50 14.47 N Unresolved disorder model. using A ATOM 691 CG ALEU 83 -7.244 -3.246 17.007 0.50 5.36 C Unresolved disorder model. using A ATOM 692 CG BLEU 83 -7.451 -3.567 16.585 0.50 5.15 C Unresolved disorder model. using A ATOM 693 CD1ALEU 83 -7.930 -2.637 18.194 0.50 5.37 C Unresolved disorder model. using A ATOM 694 CD1BLEU 83 -6.927 -2.123 16.693 0.50 5.60 C Unresolved disorder model. using A ATOM 695 CD2ALEU 83 -6.125 -2.332 16.537 0.50 3.69 C Unresolved disorder model. using A ATOM 696 CD2BLEU 83 -7.587 -3.964 15.131 0.50 5.66 C Unresolved disorder model. using A ATOM 986 CG AASP 120 28.452 -22.550 13.280 0.50 11.35 C Unresolved disorder model. using A ATOM 987 CG BASP 120 29.546 -23.405 14.904 0.50 13.33 C Unresolved disorder model. using A ATOM 988 OD1AASP 120 28.572 -22.793 12.059 0.50 12.79 O Unresolved disorder model. using A ATOM 989 OD1BASP 120 30.510 -24.166 14.697 0.50 16.10 O Unresolved disorder model. using A ATOM 990 OD2AASP 120 28.499 -21.396 13.758 0.50 11.94 O Unresolved disorder model. using A ATOM 991 OD2BASP 120 29.626 -22.401 15.645 0.50 16.15 O Unresolved disorder model. using A ATOM 1078 CB AGLU 132 18.584 -28.355 28.250 0.70 9.18 C Unresolved disorder model. using A ATOM 1079 CB BGLU 132 18.526 -28.302 28.204 0.30 8.96 C Unresolved disorder model. using A ATOM 1080 CG AGLU 132 17.058 -28.389 28.253 0.70 11.33 C Unresolved disorder model. using A ATOM 1081 CG BGLU 132 18.856 -29.383 29.210 0.30 10.56 C Unresolved disorder model. using A ATOM 1082 CD AGLU 132 16.471 -28.180 29.642 0.70 12.42 C Unresolved disorder model. using A ATOM 1083 CD BGLU 132 17.926 -29.331 30.407 0.30 10.90 C Unresolved disorder model. using A ATOM 1084 OE1AGLU 132 17.038 -27.386 30.432 0.70 14.76 O Unresolved disorder model. using A ATOM 1085 OE1BGLU 132 16.705 -29.533 30.221 0.30 11.85 O Unresolved disorder model. using A ATOM 1086 OE2AGLU 132 15.432 -28.807 29.947 0.70 16.94 O Unresolved disorder model. using A ATOM 1087 OE2BGLU 132 18.411 -29.080 31.528 0.30 12.64 O Unresolved disorder model. using A ATOM 1214 CA ALYS 149 8.308 -32.437 9.158 0.50 10.65 C Unresolved disorder model. using A ATOM 1215 CA BLYS 149 8.305 -32.432 9.148 0.50 10.72 C Unresolved disorder model. using A ATOM 1218 CB ALYS 149 7.408 -32.638 7.936 0.50 11.65 C Unresolved disorder model. using A ATOM 1219 CB BLYS 149 7.418 -32.609 7.909 0.50 11.75 C Unresolved disorder model. using A ATOM 1220 CG ALYS 149 5.925 -32.685 8.258 0.50 12.56 C Unresolved disorder model. using A ATOM 1221 CG BLYS 149 5.922 -32.430 8.151 0.50 12.96 C Unresolved disorder model. using A ATOM 1222 CD ALYS 149 5.095 -32.940 7.010 0.50 14.64 C Unresolved disorder model. using A ATOM 1223 CD BLYS 149 5.336 -33.527 9.031 0.50 14.82 C Unresolved disorder model. using A ATOM 1224 CE ALYS 149 3.718 -32.300 7.118 0.50 16.17 C Unresolved disorder model. using A ATOM 1225 CE BLYS 149 3.858 -33.280 9.285 0.50 16.07 C Unresolved disorder model. using A ATOM 1226 NZ ALYS 149 3.768 -30.828 6.892 0.50 17.34 N Unresolved disorder model. using A ATOM 1227 NZ BLYS 149 3.325 -34.142 10.376 0.50 17.59 N Unresolved disorder model. using A ATOM 1241 OG ASER 151 16.163 -34.858 9.827 0.50 9.42 O Unresolved disorder model. using A ATOM 1242 OG BSER 151 14.258 -36.128 9.100 0.50 10.52 O Unresolved disorder model. using A ATOM 1267 CG AGLU 154 10.048 -34.037 12.462 0.50 8.21 C Unresolved disorder model. using A ATOM 1268 CG BGLU 154 9.738 -34.129 12.663 0.50 8.67 C Unresolved disorder model. using A ATOM 1269 CD AGLU 154 9.982 -35.179 11.461 0.50 8.72 C Unresolved disorder model. using A ATOM 1270 CD BGLU 154 9.190 -35.397 12.005 0.50 9.61 C Unresolved disorder model. using A ATOM 1271 OE1AGLU 154 10.835 -36.090 11.516 0.50 9.56 O Unresolved disorder model. using A ATOM 1272 OE1BGLU 154 9.568 -36.510 12.419 0.50 11.60 O Unresolved disorder model. using A ATOM 1273 OE2AGLU 154 9.069 -35.164 10.612 0.50 10.98 O Unresolved disorder model. using A ATOM 1274 OE2BGLU 154 8.371 -35.277 11.072 0.50 12.02 O Unresolved disorder model. using A ATOM 1335 OG ASER 161 7.184 -32.092 22.261 0.50 13.56 O Unresolved disorder model. using A ATOM 1336 OG BSER 161 5.952 -33.173 23.867 0.50 13.20 O Unresolved disorder model. using A ATOM 1550 CE AMET 188 14.636 -13.991 23.501 0.50 5.12 C Unresolved disorder model. using A ATOM 1551 CE BMET 188 15.743 -15.246 23.251 0.50 11.30 C Unresolved disorder model. using A ATOM 1589 CA AGLU 194 19.182 -8.697 17.805 0.50 5.63 C Unresolved disorder model. using A ATOM 1590 CA BGLU 194 19.238 -8.743 17.834 0.50 5.64 C Unresolved disorder model. using A ATOM 1593 CB AGLU 194 18.516 -8.047 16.576 0.50 5.96 C Unresolved disorder model. using A ATOM 1594 CB BGLU 194 18.785 -8.180 16.479 0.50 6.17 C Unresolved disorder model. using A ATOM 1595 CG AGLU 194 19.160 -6.735 16.098 0.50 6.98 C Unresolved disorder model. using A ATOM 1596 CG BGLU 194 19.268 -9.038 15.292 0.50 7.53 C Unresolved disorder model. using A ATOM 1597 CD AGLU 194 18.256 -5.896 15.189 0.50 7.13 C Unresolved disorder model. using A ATOM 1598 CD BGLU 194 18.328 -9.059 14.083 0.50 9.30 C Unresolved disorder model. using A ATOM 1599 OE1AGLU 194 17.152 -6.351 14.811 0.50 10.27 O Unresolved disorder model. using A ATOM 1600 OE1BGLU 194 17.435 -8.194 13.971 0.50 11.38 O Unresolved disorder model. using A ATOM 1601 OE2AGLU 194 18.654 -4.760 14.855 0.50 10.17 O Unresolved disorder model. using A ATOM 1602 OE2BGLU 194 18.501 -9.956 13.227 0.50 10.93 O Unresolved disorder model. using A ATOM 1642 CB AARG 199 21.096 -5.085 25.720 0.50 10.08 C Unresolved disorder model. using A ATOM 1643 CB BARG 199 21.096 -5.085 25.726 0.50 10.10 C Unresolved disorder model. using A ATOM 1644 CG AARG 199 20.484 -3.812 25.187 0.50 9.67 C Unresolved disorder model. using A ATOM 1645 CG BARG 199 20.339 -4.041 24.907 0.50 9.29 C Unresolved disorder model. using A ATOM 1646 CD AARG 199 19.014 -3.914 24.852 0.50 9.11 C Unresolved disorder model. using A ATOM 1647 CD BARG 199 18.830 -4.138 25.085 0.50 9.93 C Unresolved disorder model. using A ATOM 1648 NE AARG 199 18.626 -2.710 24.127 0.50 9.42 N Unresolved disorder model. using A ATOM 1649 NE BARG 199 18.378 -3.706 26.406 0.50 11.91 N Unresolved disorder model. using A ATOM 1650 CZ AARG 199 18.776 -2.525 22.816 0.50 9.70 C Unresolved disorder model. using A ATOM 1651 CZ BARG 199 18.030 -2.459 26.717 0.50 13.34 C Unresolved disorder model. using A ATOM 1652 NH1AARG 199 19.279 -3.478 22.037 0.50 7.06 N Unresolved disorder model. using A ATOM 1653 NH1BARG 199 18.085 -1.496 25.805 0.50 15.31 N Unresolved disorder model. using A ATOM 1654 NH2AARG 199 18.401 -1.374 22.278 0.50 10.14 N Unresolved disorder model. using A ATOM 1655 NH2BARG 199 17.630 -2.172 27.949 0.50 14.10 N Unresolved disorder model. using A ATOM 1727 CA AILE 210 15.718 -21.305 10.195 0.50 4.67 C Unresolved disorder model. using A ATOM 1728 CA BILE 210 15.609 -21.320 10.398 0.50 5.02 C Unresolved disorder model. using A ATOM 1731 CB AILE 210 15.706 -22.409 11.266 0.50 4.42 C Unresolved disorder model. using A ATOM 1732 CB BILE 210 15.207 -21.972 11.762 0.50 4.36 C Unresolved disorder model. using A ATOM 1733 CG1AILE 210 14.610 -22.149 12.294 0.50 3.50 C Unresolved disorder model. using A ATOM 1734 CG1BILE 210 16.474 -22.332 12.559 0.50 4.67 C Unresolved disorder model. using A ATOM 1735 CG2AILE 210 17.089 -22.562 11.895 0.50 4.06 C Unresolved disorder model. using A ATOM 1736 CG2BILE 210 14.277 -23.165 11.581 0.50 6.23 C Unresolved disorder model. using A ATOM 1737 CD1AILE 210 14.373 -23.318 13.212 0.50 3.67 C Unresolved disorder model. using A ATOM 1738 CD1BILE 210 16.242 -22.792 14.003 0.50 4.75 C Unresolved disorder model. using A ATOM 1879 CD1AILE 229 -6.829 -3.129 12.608 0.50 5.40 C Unresolved disorder model. using A ATOM 1880 CD1BILE 229 -5.536 -1.097 12.616 0.50 6.10 C Unresolved disorder model. using A ATOM 1905 CB AILE 233 0.435 -1.926 8.083 0.50 2.05 C Unresolved disorder model. using A ATOM 1906 CB BILE 233 0.424 -1.901 8.115 0.50 1.59 C Unresolved disorder model. using A ATOM 1907 CG1AILE 233 -0.211 -2.179 9.455 0.50 3.34 C Unresolved disorder model. using A ATOM 1908 CG1BILE 233 0.240 -2.062 9.624 0.50 1.63 C Unresolved disorder model. using A ATOM 1909 CG2AILE 233 1.837 -2.558 7.974 0.50 3.00 C Unresolved disorder model. using A ATOM 1910 CG2BILE 233 1.679 -2.641 7.616 0.50 2.27 C Unresolved disorder model. using A ATOM 1911 CD1AILE 233 0.634 -1.796 10.643 0.50 5.00 C Unresolved disorder model. using A ATOM 1912 CD1BILE 233 -0.332 -3.391 9.995 0.50 0.68 C Unresolved disorder model. using A ATOM 1974 CG ALYS 241 6.031 6.023 11.303 0.50 6.36 C Unresolved disorder model. using A ATOM 1975 CG BLYS 241 6.242 7.269 9.624 0.50 6.64 C Unresolved disorder model. using A ATOM 1976 CD ALYS 241 6.799 7.221 11.830 0.50 9.27 C Unresolved disorder model. using A ATOM 1977 CD BLYS 241 4.817 7.717 9.869 0.50 9.22 C Unresolved disorder model. using A ATOM 1978 CE ALYS 241 6.845 7.236 13.338 0.50 11.35 C Unresolved disorder model. using A ATOM 1979 CE BLYS 241 4.711 9.217 10.006 0.50 10.86 C Unresolved disorder model. using A ATOM 1980 NZ ALYS 241 7.725 8.328 13.823 0.50 12.07 N Unresolved disorder model. using A ATOM 1981 NZ BLYS 241 3.361 9.587 10.508 0.50 11.65 N Unresolved disorder model. using A ATOM 2005 CG AMET 244 12.104 7.060 10.784 0.50 11.34 C Unresolved disorder model. using A ATOM 2006 CG BMET 244 11.691 6.825 10.447 0.50 11.22 C Unresolved disorder model. using A ATOM 2007 SD AMET 244 11.353 8.694 10.681 0.50 12.98 S Unresolved disorder model. using A ATOM 2008 SD BMET 244 10.523 8.151 10.070 0.50 13.30 S Unresolved disorder model. using A ATOM 2009 CE AMET 244 11.014 9.008 12.410 0.50 10.48 C Unresolved disorder model. using A ATOM 2010 CE BMET 244 10.961 8.503 8.368 0.50 12.71 C Unresolved disorder model. using A ATOM 2147 CA AILE 262 -9.910 -16.101 -14.842 0.50 3.48 C Unresolved disorder model. using A ATOM 2148 CA BILE 262 -9.914 -16.102 -14.838 0.50 3.54 C Unresolved disorder model. using A ATOM 2151 CB AILE 262 -10.773 -15.027 -15.541 0.50 3.72 C Unresolved disorder model. using A ATOM 2152 CB BILE 262 -10.806 -15.045 -15.523 0.50 3.85 C Unresolved disorder model. using A ATOM 2153 CG1AILE 262 -11.882 -15.687 -16.365 0.50 5.32 C Unresolved disorder model. using A ATOM 2154 CG1BILE 262 -12.100 -15.696 -16.040 0.50 5.41 C Unresolved disorder model. using A ATOM 2155 CG2AILE 262 -9.900 -14.129 -16.430 0.50 3.51 C Unresolved disorder model. using A ATOM 2156 CG2BILE 262 -10.035 -14.305 -16.632 0.50 3.89 C Unresolved disorder model. using A ATOM 2157 CD1AILE 262 -12.969 -14.724 -16.827 0.50 4.63 C Unresolved disorder model. using A ATOM 2158 CD1BILE 262 -11.899 -16.780 -17.101 0.50 5.96 C Unresolved disorder model. using A ATOM 2342 CB AASP 285 -0.073 -25.861 -22.930 0.80 9.72 C Unresolved disorder model. using A ATOM 2343 CB BASP 285 -0.099 -25.839 -22.958 0.20 9.12 C Unresolved disorder model. using A ATOM 2344 CG AASP 285 -0.815 -26.939 -22.158 0.80 11.68 C Unresolved disorder model. using A ATOM 2345 CG BASP 285 1.016 -26.870 -23.032 0.20 9.55 C Unresolved disorder model. using A ATOM 2346 OD1AASP 285 -0.773 -26.929 -20.907 0.80 12.52 O Unresolved disorder model. using A ATOM 2347 OD1BASP 285 1.609 -27.200 -21.983 0.20 9.07 O Unresolved disorder model. using A ATOM 2348 OD2AASP 285 -1.444 -27.802 -22.805 0.80 16.33 O Unresolved disorder model. using A ATOM 2349 OD2BASP 285 1.286 -27.365 -24.146 0.20 10.20 O Unresolved disorder model. using A ATOM 2484 CA ALEU 302 -8.078 -24.285 -3.133 0.50 5.68 C Unresolved disorder model. using A ATOM 2485 CA BLEU 302 -8.078 -24.323 -3.092 0.50 5.77 C Unresolved disorder model. using A ATOM 2488 CB ALEU 302 -7.985 -22.832 -3.641 0.50 5.18 C Unresolved disorder model. using A ATOM 2489 CB BLEU 302 -7.957 -22.831 -3.426 0.50 5.51 C Unresolved disorder model. using A ATOM 2490 CG ALEU 302 -7.751 -21.676 -2.659 0.50 4.80 C Unresolved disorder model. using A ATOM 2491 CG BLEU 302 -6.855 -22.162 -2.584 0.50 5.45 C Unresolved disorder model. using A ATOM 2492 CD1ALEU 302 -6.305 -21.648 -2.217 0.50 4.50 C Unresolved disorder model. using A ATOM 2493 CD1BLEU 302 -6.601 -20.738 -3.032 0.50 5.08 C Unresolved disorder model. using A ATOM 2494 CD2ALEU 302 -8.135 -20.344 -3.295 0.50 5.17 C Unresolved disorder model. using A ATOM 2495 CD2BLEU 302 -7.172 -22.224 -1.099 0.50 6.13 C Unresolved disorder model. using A ATOM 2532 CA AASP 307 -7.669 -19.718 -17.499 0.70 5.36 C Unresolved disorder model. using A ATOM 2533 CA BASP 307 -7.687 -19.726 -17.489 0.30 4.92 C Unresolved disorder model. using A ATOM 2536 CB AASP 307 -8.903 -19.249 -18.268 0.70 6.14 C Unresolved disorder model. using A ATOM 2537 CB BASP 307 -8.976 -19.318 -18.202 0.30 5.32 C Unresolved disorder model. using A ATOM 2538 CG AASP 307 -9.772 -20.379 -18.741 0.70 9.29 C Unresolved disorder model. using A ATOM 2539 CG BASP 307 -8.861 -19.366 -19.707 0.30 6.30 C Unresolved disorder model. using A ATOM 2540 OD1AASP 307 -9.272 -21.513 -18.909 0.70 12.19 O Unresolved disorder model. using A ATOM 2541 OD1BASP 307 -7.731 -19.420 -20.232 0.30 6.76 O Unresolved disorder model. using A ATOM 2542 OD2AASP 307 -10.974 -20.119 -18.957 0.70 13.06 O Unresolved disorder model. using A ATOM 2543 OD2BASP 307 -9.923 -19.347 -20.366 0.30 7.74 O Unresolved disorder model. using A ATOM 2788 CB ALEU 339 -6.715 -14.417 -8.843 0.50 3.81 C Unresolved disorder model. using A ATOM 2789 CB BLEU 339 -6.584 -14.533 -9.209 0.50 3.64 C Unresolved disorder model. using A ATOM 2790 CG ALEU 339 -6.492 -15.762 -9.523 0.50 4.12 C Unresolved disorder model. using A ATOM 2791 CG BLEU 339 -7.304 -15.694 -8.521 0.50 3.94 C Unresolved disorder model. using A ATOM 2792 CD1ALEU 339 -5.946 -16.758 -8.516 0.50 3.26 C Unresolved disorder model. using A ATOM 2793 CD1BLEU 339 -7.865 -15.290 -7.170 0.50 4.91 C Unresolved disorder model. using A ATOM 2794 CD2ALEU 339 -7.765 -16.325 -10.160 0.50 4.60 C Unresolved disorder model. using A ATOM 2795 CD2BLEU 339 -8.363 -16.314 -9.411 0.50 6.66 C Unresolved disorder model. using A ATOM 3171 CA AGLU 388 19.220 9.069 -18.940 0.60 8.12 C Unresolved disorder model. using A ATOM 3172 CA BGLU 388 19.253 9.111 -18.862 0.40 7.87 C Unresolved disorder model. using A ATOM 3175 CB AGLU 388 18.477 8.911 -20.288 0.60 8.06 C Unresolved disorder model. using A ATOM 3176 CB BGLU 388 18.441 9.182 -20.155 0.40 8.21 C Unresolved disorder model. using A ATOM 3177 CG AGLU 388 16.972 9.280 -20.304 0.60 9.05 C Unresolved disorder model. using A ATOM 3178 CG BGLU 388 18.712 10.461 -20.939 0.40 9.87 C Unresolved disorder model. using A ATOM 3179 CD AGLU 388 16.349 9.243 -21.704 0.60 10.11 C Unresolved disorder model. using A ATOM 3180 CD BGLU 388 17.966 10.517 -22.254 0.40 11.86 C Unresolved disorder model. using A ATOM 3181 OE1AGLU 388 17.006 8.742 -22.647 0.60 14.28 O Unresolved disorder model. using A ATOM 3182 OE1BGLU 388 16.718 10.577 -22.231 0.40 12.93 O Unresolved disorder model. using A ATOM 3183 OE2AGLU 388 15.195 9.704 -21.870 0.60 11.48 O Unresolved disorder model. using A ATOM 3184 OE2BGLU 388 18.631 10.520 -23.313 0.40 14.38 O Unresolved disorder model. using A ATOM 3332 OG ASER 407 16.305 15.697 -1.648 0.50 9.35 O Unresolved disorder model. using A ATOM 3333 OG BSER 407 14.444 17.014 -0.906 0.50 10.18 O Unresolved disorder model. using A ATOM 3418 CA ASER 417 8.301 13.056 -16.508 0.50 6.25 C Unresolved disorder model. using A ATOM 3419 CA BSER 417 8.297 13.020 -16.519 0.50 6.38 C Unresolved disorder model. using A ATOM 3422 CB ASER 417 7.591 13.876 -15.433 0.50 6.70 C Unresolved disorder model. using A ATOM 3423 CB BSER 417 7.493 13.731 -15.424 0.50 6.68 C Unresolved disorder model. using A ATOM 3424 OG ASER 417 7.121 13.050 -14.399 0.50 6.57 O Unresolved disorder model. using A ATOM 3425 OG BSER 417 6.290 14.277 -15.939 0.50 8.59 O Unresolved disorder model. using A ATOM 3517 CB AASP 429 11.405 -6.910 -23.056 0.50 8.57 C Unresolved disorder model. using A ATOM 3518 CB BASP 429 11.345 -6.833 -23.093 0.50 8.20 C Unresolved disorder model. using A ATOM 3519 CG AASP 429 12.282 -8.019 -23.582 0.50 11.16 C Unresolved disorder model. using A ATOM 3520 CG BASP 429 11.263 -8.292 -22.675 0.50 9.11 C Unresolved disorder model. using A ATOM 3521 OD1AASP 429 13.234 -7.722 -24.335 0.50 14.42 O Unresolved disorder model. using A ATOM 3522 OD1BASP 429 12.104 -8.751 -21.872 0.50 11.47 O Unresolved disorder model. using A ATOM 3523 OD2AASP 429 12.025 -9.192 -23.233 0.50 13.48 O Unresolved disorder model. using A ATOM 3524 OD2BASP 429 10.358 -8.987 -23.181 0.50 11.22 O Unresolved disorder model. using A ATOM 3551 CG AGLN 433 17.351 -3.993 -26.747 0.50 11.51 C Unresolved disorder model. using A ATOM 3552 CG BGLN 433 17.296 -3.796 -26.839 0.50 11.99 C Unresolved disorder model. using A ATOM 3553 CD AGLN 433 16.501 -4.446 -27.909 0.50 11.75 C Unresolved disorder model. using A ATOM 3554 CD BGLN 433 18.203 -5.027 -26.838 0.50 12.25 C Unresolved disorder model. using A ATOM 3555 OE1AGLN 433 15.662 -3.697 -28.411 0.50 13.82 O Unresolved disorder model. using A ATOM 3556 OE1BGLN 433 18.000 -5.973 -26.075 0.50 13.08 O Unresolved disorder model. using A ATOM 3557 NE2AGLN 433 16.722 -5.675 -28.354 0.50 11.64 N Unresolved disorder model. using A ATOM 3558 NE2BGLN 433 19.203 -5.019 -27.711 0.50 14.63 N Unresolved disorder model. using A ATOM 3641 CA AMET 444 13.594 -1.814 -11.261 0.50 2.27 C Unresolved disorder model. using A ATOM 3642 CA BMET 444 13.693 -1.879 -11.329 0.50 3.98 C Unresolved disorder model. using A ATOM 3645 CB AMET 444 13.947 -2.625 -12.488 0.50 3.45 C Unresolved disorder model. using A ATOM 3646 CB BMET 444 14.199 -2.696 -12.547 0.50 4.81 C Unresolved disorder model. using A ATOM 3647 CG AMET 444 15.408 -2.873 -12.568 0.50 0.76 C Unresolved disorder model. using A ATOM 3648 CG BMET 444 15.205 -3.823 -12.285 0.50 7.32 C Unresolved disorder model. using A ATOM 3649 SD AMET 444 15.892 -3.860 -13.986 0.50 2.74 S Unresolved disorder model. using A ATOM 3650 SD BMET 444 15.597 -5.018 -13.631 0.50 8.08 S Unresolved disorder model. using A ATOM 3651 CE AMET 444 15.368 -5.517 -13.568 0.50 3.13 C Unresolved disorder model. using A ATOM 3652 CE BMET 444 15.880 -3.927 -15.000 0.50 10.60 C Unresolved disorder model. using A ATOM 3693 CB AGLU 450 18.782 -11.065 -8.248 0.50 6.42 C Unresolved disorder model. using A ATOM 3694 CB BGLU 450 18.662 -11.115 -8.310 0.50 6.31 C Unresolved disorder model. using A ATOM 3695 CG AGLU 450 19.294 -10.241 -7.058 0.50 7.66 C Unresolved disorder model. using A ATOM 3696 CG BGLU 450 19.174 -12.508 -7.925 0.50 7.58 C Unresolved disorder model. using A ATOM 3697 CD AGLU 450 18.368 -10.245 -5.846 0.50 9.18 C Unresolved disorder model. using A ATOM 3698 CD BGLU 450 18.315 -13.214 -6.866 0.50 8.00 C Unresolved disorder model. using A ATOM 3699 OE1AGLU 450 17.556 -11.183 -5.695 0.50 10.80 O Unresolved disorder model. using A ATOM 3700 OE1BGLU 450 17.256 -12.680 -6.460 0.50 10.19 O Unresolved disorder model. using A ATOM 3701 OE2AGLU 450 18.469 -9.304 -5.029 0.50 11.43 O Unresolved disorder model. using A ATOM 3702 OE2BGLU 450 18.699 -14.321 -6.447 0.50 11.46 O Unresolved disorder model. using A ATOM 3742 CB AARG 455 21.021 -14.202 -17.471 0.50 9.37 C Unresolved disorder model. using A ATOM 3743 CB BARG 455 21.018 -14.204 -17.471 0.50 9.47 C Unresolved disorder model. using A ATOM 3744 CG AARG 455 20.494 -15.492 -16.917 0.50 9.72 C Unresolved disorder model. using A ATOM 3745 CG BARG 455 20.367 -15.306 -16.650 0.50 9.84 C Unresolved disorder model. using A ATOM 3746 CD AARG 455 19.029 -15.437 -16.562 0.50 9.07 C Unresolved disorder model. using A ATOM 3747 CD BARG 455 18.854 -15.253 -16.723 0.50 10.72 C Unresolved disorder model. using A ATOM 3748 NE AARG 455 18.681 -16.659 -15.845 0.50 9.23 N Unresolved disorder model. using A ATOM 3749 NE BARG 455 18.339 -15.424 -18.080 0.50 12.72 N Unresolved disorder model. using A ATOM 3750 CZ AARG 455 18.810 -16.837 -14.530 0.50 9.51 C Unresolved disorder model. using A ATOM 3751 CZ BARG 455 18.073 -16.596 -18.651 0.50 13.68 C Unresolved disorder model. using A ATOM 3752 NH1AARG 455 18.478 -18.002 -14.003 0.50 9.00 N Unresolved disorder model. using A ATOM 3753 NH1BARG 455 17.602 -16.631 -19.891 0.50 14.63 N Unresolved disorder model. using A ATOM 3754 NH2AARG 455 19.251 -15.862 -13.737 0.50 6.72 N Unresolved disorder model. using A ATOM 3755 NH2BARG 455 18.273 -17.732 -17.994 0.50 14.80 N Unresolved disorder model. using A ATOM 3827 CA AILE 466 15.823 2.129 -1.972 0.50 5.10 C Unresolved disorder model. using A ATOM 3828 CA BILE 466 15.729 2.150 -2.160 0.50 5.46 C Unresolved disorder model. using A ATOM 3831 CB AILE 466 15.833 3.223 -3.055 0.50 4.72 C Unresolved disorder model. using A ATOM 3832 CB BILE 466 15.378 2.835 -3.529 0.50 5.08 C Unresolved disorder model. using A ATOM 3833 CG1AILE 466 14.741 2.971 -4.098 0.50 3.92 C Unresolved disorder model. using A ATOM 3834 CG1BILE 466 16.664 3.275 -4.249 0.50 5.98 C Unresolved disorder model. using A ATOM 3835 CG2AILE 466 17.226 3.335 -3.676 0.50 5.27 C Unresolved disorder model. using A ATOM 3836 CG2BILE 466 14.411 3.999 -3.367 0.50 5.86 C Unresolved disorder model. using A ATOM 3837 CD1AILE 466 14.540 4.129 -5.067 0.50 4.32 C Unresolved disorder model. using A ATOM 3838 CD1BILE 466 16.490 3.645 -5.724 0.50 5.25 C Unresolved disorder model. using A ATOM 3977 CG1AILE 485 -6.179 -17.031 -3.574 0.50 4.40 C Unresolved disorder model. using A ATOM 3978 CG1BILE 485 -6.151 -17.089 -3.563 0.50 4.05 C Unresolved disorder model. using A ATOM 3979 CG2AILE 485 -3.871 -16.161 -2.937 0.50 4.29 C Unresolved disorder model. using A ATOM 3980 CG2BILE 485 -3.878 -16.215 -2.966 0.50 4.23 C Unresolved disorder model. using A ATOM 3981 CD1AILE 485 -5.534 -18.033 -4.527 0.50 5.48 C Unresolved disorder model. using A ATOM 3982 CD1BILE 485 -6.799 -16.053 -4.466 0.50 3.98 C 1